Cargando…
Pathophysiological role of host microbiota in the development of obesity
Overweight and obesity increase the risk for a number of diseases, namely, cardiovascular diseases, type 2 diabetes, dyslipidemia, premature death, non-alcoholic fatty liver disease as well as different types of cancer. Approximately 1.7 billion people in the world suffer from being overweight, most...
Autores principales: | Kobyliak, Nazarii, Virchenko, Oleksandr, Falalyeyeva, Tetyana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841968/ https://www.ncbi.nlm.nih.gov/pubmed/27105827 http://dx.doi.org/10.1186/s12937-016-0166-9 |
Ejemplares similares
-
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
por: Savcheniuk, Oleksandr, et al.
Publicado: (2014) -
Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles
por: KOBYLIAK, NAZARII, et al.
Publicado: (2016) -
Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019) -
Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention
por: Kobyliak, Nazarii, et al.
Publicado: (2016) -
Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)